TABLE 2.
Patient‐Level Characteristics of Cancers with atrial fibrillation versus Cancers without atrial fibrillation in 2005‐2015 of Patients age 65‐80
| Characteristics | Cancers with AF | Cancers without AF | P‐value |
|---|---|---|---|
| N = 18 684 706 | N = 3 076 666 (16.5%) | N = 15 608 040 (83.5%) | |
| Gender | |||
| Male | 1 792 995 (58.3%) | 7 924 758 (50.8%) | <.0001 |
| Female | 1 283 525 (41.7%) | 7 679 425 (49.2%) | |
| *Missing – 4003 | |||
| Race | |||
| Caucasians | 2 353 070 (76.5%) | 10 654 565 (68.3%) | <.0001 |
| African‐Americans | 176 748 (5.7%) | 1 445 919 (9.3%) | |
| Others | 546 735 (17.8%) | 3 506 546 (22.5%) | |
| *Missing – 1123 | |||
| BMI | <.0001 | ||
| Cancers | |||
| Colon | 325 335 (10.65%) | 1 659 302 (10.63%) | .003 |
| Pancreas | 49 049 (1.6%) | 362 896 (2.3%) | <.0001 |
| Lung | 578 309 (18.8%) | 2 477 666 (15.9%) | <.0001 |
| Other respiratory | 6469 (0.24%) | 31 572 (0.21%) | .005 |
| Breast | 447 345 (14.5%) | 2 483 820 (15.9%) | <.0001 |
| Prostate | 538 850 (17.5%) | 2 564 687 (16.4%) | <.0001 |
| Thyroid | 36 886 (1.2%) | 199 940 (1.3%) | <.0001 |
| Hodgkins | 14 896 (0.5%) | 59 563 (0.4%) | <.0001 |
| Non‐Hodgkins | 190 080 (6.2%) | 874 527 (5.6%) | <.0001 |
| Leukemia | 147 709 (4.8%) | 671 398 (4.3%) | <.0001 |
| Multiple myeloma | 84 372 (2.7%) | 373 153 (2.4%) | <.0001 |
| AHRQ comorbidities | |||
| Coronary arterial disease | 1 127 748 (36.6%) | 3 714 817 (23.8%) | <.0001 |
| Obstructive sleep apnea | 213 675 (6.9%) | 553 450 (3.5%) | <.0001 |
| Congestive heart failure | 223 895 (7.3%) | 363 096 (2.3%) | <.0001 |
| Valvular disease | 274 048 (8.9%) | 573 855 (3.7%) | <.0001 |
| Chronic pulmonary disease | 989 132 (32.1%) | 3 745 872 (24%) | <.0001 |
| Hypertension | 2 051 799 (66.7%) | 9 586 878 (61.4%) | <.0001 |
| Diabetes mellitus | 967 174 (31.4%) | 4 251 791 (27.2%) | <.0001 |
| Hypothyroidism | 470 337 (15.3%) | 2 017 313 (12.9%) | <.0001 |
| Renal failure | 569 866 (18.5%) | 1 796 852 (11.5%) | <.0001 |
| Obesity | 312 301 (10.1%) | 1 167 477 (7.5%) | <.0001 |
| Alcohol abuse | 70 535 (2.3%) | 323 822 (2.1%) | <.0001 |
| Drug abuse | 12 832 (0.4%) | 84 183 (0.5%) | <.0001 |
| RA/Collagen Vascular Disease | 93 517 (3%) | 430 026 (2.8%) | <.0001 |
| Outcomes | |||
|
In‐hospital mortality *Missing – 8544 |
183 767 (5.9%) | 637 237 (4.1%) | <.0001 |
|
Adjusted odds ratioa 1.31 (1.30‐1.32) |
<.0001 | ||
| Length of stay, days (mean ± SD) | 6.5 ± 6.9 | 5.4 ± 6.2 | <.0001 |
| Total hospitalization cost, $ (mean ± SD) | 15 994 ± 20 353 | 13 144 ± 16 108 | <.0001 |
a
Adjusted for race, gender, AHRQ comorbidities